A clinical trial starting in early 2027 by the Center for Addiction Science, Policy and Research and Allegheny County will evaluate weekly semaglutide injections in 1,200 participants with substance use disorders.

From the articleNew study examines GLP-1 impact on interactions with criminal justice system, employment, housing stability